Corcept Therapeutics (CORT) Gross Profit Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.69% |
| Dec 31, 2025 | 18.76% |
| Sep 30, 2025 | 18.99% |
| Jun 30, 2025 | 16.94% |
| Mar 31, 2025 | 11.12% |
| Dec 31, 2024 | 15.66% |
| Sep 30, 2024 | 17.55% |
| Jun 30, 2024 | 17.87% |
| Mar 31, 2024 | 17.80% |
| Dec 31, 2023 | 15.40% |
| Sep 30, 2023 | 14.07% |
| Jun 30, 2023 | 13.69% |
| Mar 31, 2023 | 13.04% |
| Dec 31, 2022 | 14.28% |
| Sep 30, 2022 | 19.16% |
| Jun 30, 2022 | 24.02% |
| Mar 31, 2022 | 27.95% |
| Dec 31, 2021 | 33.19% |
| Sep 30, 2021 | 35.12% |
| Jun 30, 2021 | 36.13% |
| Mar 31, 2021 | 37.93% |
| Dec 31, 2020 | 42.06% |
| Sep 30, 2020 | 45.60% |
| Jun 30, 2020 | 49.96% |
| Mar 31, 2020 | 56.28% |
| Dec 31, 2019 | 58.09% |
| Sep 30, 2019 | 62.58% |
| Jun 30, 2019 | 65.92% |
| Mar 31, 2019 | 71.94% |
| Dec 31, 2018 | 74.32% |
| Sep 30, 2018 | 89.35% |
| Jun 30, 2018 | 100.92% |
| Mar 31, 2018 | 101.58% |
| Dec 31, 2017 | 107.41% |
| Sep 30, 2017 | 109.68% |
| Jun 30, 2017 | 111.24% |